Study of Digital Health and Neuromodulation Therapies Using TENS and NMES for Treatment of Diabetic Neuropathy in Adults Aged 55 to 65

What this Trial Is About

Researchers are evaluating the effects of digital health combined with neuromodulation therapies on sensory and motor functions in patients with diabetic neuropathy. The study involves 60 male and female patients aged 55 to 65 years with type II diabetes and peripheral neuropathy. Participants are randomly assigned to two groups to assess the impact of these therapies alongside their medical treatment. One group of 30 patients will receive active transcutaneous electrical nerve stimulation TENS and neuromuscular electrical stimulation NMES for 30 minutes, three times a week, over 10 weeks, together with their standard medical care. The control group will receive placebo versions of these therapies following the same schedule and duration, also alongside medical treatment. During the study, participants will undergo several assessments including nerve conduction velocity and electromyography at 10 weeks. Additional monitoring involves digital tools such as the Google Fit app, Manage My Pain app, and the PEDIS Score Diabetes App to track symptoms and activity levels. The research team will monitor outcomes related to nerve function and patient-reported measures throughout the 10-week treatment period.

Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy